VCL-CB01 Vaccine

Preferred Label : VCL-CB01 Vaccine;

NCIt definition : A vaccine consisting of two plasmids encoding the human cytomegalovirus (CMV) tegument phosphoprotein 65 (pp65), a major internal matrix protein, and glycoprotein B (gB), an important CMV component responsible for attachment and entry into cells, with immunostimulatory properties. Vaccination with VCL-CB01 may stimulate the host immune system to mount cellular and humoral immune responses against CMV positive cells, resulting in cell lysis.;

Details

Origin ID

C61327;

UMLS CUI

C1831826;

Currated CISMeF NLP mapping
- VCL-CB01 vaccine [MeSH concept]
- VCL-CB01 vaccine [MeSH Supplementary Concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- VCL-CB01 vaccine [MeSH concept]
- VCL-CB01 vaccine [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
has_target
- 65 kDa Phosphoprotein [NCIt concept]
- Human Cytomegalovirus Envelope Glycoprotein B [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients